ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

3.10
Delayed Data
As of Apr 17
 -0.01 / -0.32%
Today’s Change
0.65
Today|||52-Week Range
5.15
+39.64%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 6.80, with a high estimate of 6.80 and a low estimate of 6.80. The median estimate represents a +119.35% increase from the last price of 3.10.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
--
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually --

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account